Category: Health Services

Global Transthyretin Amyloidosis Treatment Market | PMI Global Transthyretin Amyloidosis Treatment Market–Analysis and Demand with Forecast Overview to 2029 Published Date:December 2020 Robust pipeline of transthyretin amyloidosis treatment is one of the major factors that is expected to propel growth of the market over the forecast period. The global transthyretin amyloidosis treatment market accounted for US$ 40.5 million in 2019 and is anticipated to register a CAGR of 58.7%. The report "Global Transthyretin Amyloidosis Treatment Market, By Medicine (Inostersen, Partisiran, Tafamidis, and Others), By Indication (Wild Type ATTR Amyloidosis, and Hereditary ATTR Amyloidosis), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.